N
FLNA

Nuveen’s Filana Therapeutics FLNA Stock Holding History

Nuveen’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69,200
Closed -$1.95M – 3391
2025
Q1 		$1.95M Sell
69,200
-96,314
-58% -$243K ﹤0.01% 2345
2024
Q4 		$391K Sell
165,514
-10,321
-6% -$181K ﹤0.01% 3064
2024
Q3 		$5.17M Buy
175,835
+6,625
+4% +$153K ﹤0.01% 1970
2024
Q2 		$2.09M Buy
169,210
+6,999
+4% +$148K ﹤0.01% 2372
2024
Q1 		$3.29M Sell
162,211
-116,323
-42% -$2.68M ﹤0.01% 2172
2023
Q4 		$6.27M Buy
278,534
+87,663
+46% +$1.85M ﹤0.01% 1854
2023
Q3 		$3.18M Sell
190,871
-48,852
-20% -$968K ﹤0.01% 2093
2023
Q2 		$5.88M Buy
239,723
+4,352
+2% +$105K ﹤0.01% 1819
2023
Q1 		$5.68M Buy
235,371
+152
+0.1% +$4.21K ﹤0.01% 1816
2022
Q4 		$6.95M Buy
235,219
+80,904
+52% +$2.91M ﹤0.01% 1725
2022
Q3 		$6.45M Sell
154,315
-5,526
-3% -$149K ﹤0.01% 1742
2022
Q2 		$4.49M Sell
159,841
-86,310
-35% -$2.18M ﹤0.01% 2014
2022
Q1 		$9.41M Buy
246,151
+8,740
+4% +$370K ﹤0.01% 1681
2021
Q4 		$10.4M Sell
237,411
-100,551
-30% -$5.27M ﹤0.01% 1669
2021
Q3 		$21M Sell
337,962
-66,497
-16% -$5.55M 0.01% 1245
2021
Q2 		$1.34M Sell
404,459
-73,382
-15% -$3.93M ﹤0.01% 2886
2021
Q1 		$1.59M Sell
477,841
-134,022
-22% -$5.27M ﹤0.01% 2718
2020
Q4 		$2.03M Buy
611,863
+520,414
+569% +$4.65M ﹤0.01% 2504
2020
Q3 		$304K Sell
91,449
-32,320
-26% -$146K ﹤0.01% 3085
2020
Q2 		$382K Buy
+123,769
New +$561K ﹤0.01% 2992

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Nuveen's FLNA Position: Q2 2025 in Review

Nuveen sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 69,200 shares — an estimated $1.95M sold.

Nuveen first reported a position in FLNA in Q2 2020 and held it in 20 quarters. The position peaked at $21M in Q3 2021. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Nuveen reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 69,200 Filana Therapeutics shares in Q2 2025, an estimated $1.95M.
  • Nuveen first reported a position in Filana Therapeutics in Q2 2020 and held it in 20 quarters.
  • Nuveen's Filana Therapeutics position peaked at $21M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.